# Major Recall Alert: Augmentin 625mg Tablets Recalled Due to Circulation of Counterfeit Batch No. AC3N in Nigeria
Consumers in Nigeria should be on high alert as a concerning recall has been issued for counterfeit or falsified **Augmentin 625mg tablets, Batch No. AC3N**. The affected product, which falsely bears the branding of healthcare manufacturer **GlaxoSmithKline (GSK)**, has been flagged by regulatory agencies for posing serious health risks.
If you use this widely-known antibiotic or are a distributor, it's crucial to keep reading for details on how to protect your health and that of others.
---
## Why This Recall is Important
Counterfeit medicines pose a significant threat to public health, especially when it comes to essential antibiotics like **Augmentin 625mg tablets**, commonly prescribed for bacterial infections. The identification of falsified versions of this drug with **Batch No. AC3N** raises concerns of both inefficacy and potential harm.
Falsified drugs often:
- Contain wrong or incorrect active ingredients.
- Lack therapeutic effect, causing treatment failure.
- Include harmful substances that may lead to adverse health effects.
The regulatory body responsible, **NAFDAC (National Agency for Food and Drug Administration and Control)**, has issued Public Alert No. 024/2026 to warn Nigerians of the counterfeit batch in circulation. Ensuring public safety means immediate action is required to remove these fake products from the market and prevent their use.
---
## Details of the Recall
NAFDAC’s investigation identified the counterfeit **Augmentin 625mg tablets** with **Batch No. AC3N** in circulation in Nigeria. The product falsely claims to be manufactured by **GlaxoSmithKline (GSK)**, a trusted name in the pharmaceutical industry.
### Key Details About the Counterfeit Alert:
- **Product Name**: Augmentin 625mg Tablets
- **Brand**: GlaxoSmithKline (alleged)
- **Batch Number:** AC3N
- **Recall Reason:** Circulation of counterfeit/falsified drugs
- **Recall Announcement Date:** [Insert Correct Date Here]
- **Regions Affected:** Nigeria
Consumers and healthcare professionals are urged not to take this lightly, as counterfeit drugs can jeopardize lives. Immediate steps should be taken to stop their use and distribution.
For the official public alert and more detailed instructions, click [here](https://nafdac.gov.ng/public-alert-no-024-2026-alert-on-counterfeit-augmentin-625mg-tablets-batch-no-ac3n-in-nigeria/).
---
## What You Should Do
If you possess or suspect you have counterfeit **Augmentin 625mg tablets** under Batch No. AC3N, follow these steps:
### Consumers:
- **Stop using the product immediately** if your tablet falls under the affected batch.
- Consult a **qualified healthcare professional** for advice and alternative treatments.
- Check your medicine packaging and confirm its authenticity with a licensed pharmacist or healthcare provider.
### Healthcare Professionals:
- **Quarantine and discontinue** the sale or distribution of the suspected counterfeit batch.
- Notify **NAFDAC** or your local health authority with any information about stocks of the affected product.
Reporting counterfeit medications helps authorities identify and eliminate dangerous products from the market. Take initiative and act now to protect public health.
---
## Stay Safe – Get Instant Recall Alerts
In today’s world, staying informed about medical recalls and counterfeit information can save lives. **Don’t take chances with your health**. Download our **[Recall Notification App]** to receive:
- Real-time alerts about product recalls in your region.
- Guidance on what to do in case of affected products.
- Tips for verifying drug authenticity.
Stay one step ahead of counterfeit products. **[Download Now!](#)**
---
Counterfeit medicines are a serious public health crisis, and collective action is crucial to stop their circulation. For more information about this recall, visit NAFDAC's [official alert page](https://nafdac.gov.ng/public-alert-no-024-2026-alert-on-counterfeit-augmentin-625mg-tablets-batch-no-ac3n-in-nigeria/). Spread the word to ensure others stay informed, too.
Let’s make safety a priority for everyone!